tocilizumab
A return to ‘pre-pandemic levels’
Shortages of intravenous and subcutaneous Actemra have been resolved as pharmacists thanked for their patience A shortage of Actemra (tocilizumab) has finally been resolved after supply was battered following recommendations …
Shortage continues
TGA warns of continuing shortages of an arthritis treatment, but says the situation may be easing The Therapeutic Goods Administration (TGA) says there may be some light at the end …
Pharmacist substitution extended
Supply is improving for tocilizumab (Actemra) products but disruptions to some products will continue beyond this month, warns Roche Availability of tocilizumab (Actemra) products is “improving” and supply should be …
Extending the date
TGA issues guidance on post-expiry date usage of shortage-impacted treatment The Therapeutic Goods Administration says tocilizumab vials continue to be stable for a further six months past their labelled expiry …
Struggling for supply
Shortage notice issued for multiple presentations of arthritis treatment The Therapeutic Goods Administration (TGA) has issued a warning regarding shortages of multiple presentations of tocilizumab (Actemra). Roche, the sponsor of …